Jane Street
FRTX

Jane Street’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Jane Street’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,093
Closed -$18K – 10729
2022
Q2 		$18K Buy
+3,093
New +$28K ﹤0.01% 9194
2020
Q3 		– Sell
-256
Closed -$12K – 8146
2020
Q2 		$12K Buy
+256
New +$13.6K ﹤0.01% 6988
2013
Q4 		– Sell
-5
Closed -$21K – 3007
2013
Q3 		$21K Buy
+5
New +$37.5K ﹤0.01% 2645

Other funds holding FRTX

TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street's FRTX Position: Q3 2022 in Review

Jane Street sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q3 2022, closing a stake of 3,093 shares — an estimated $18K sold.

Jane Street first reported a position in FRTX in Q3 2013 and held it in 3 quarters. The position peaked at $21K in Q3 2013. 17 funds tracked by Wall St. Rank hold FRTX as of Q3 2022.

  • Jane Street reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Jane Street sold 3,093 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $18K.
  • Jane Street first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q3 2013 and held it in 3 quarters.
  • Jane Street's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $21K in Q3 2013.
  • 17 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Jane Street's 13F filing for Q3 2022, filed 15 Nov 2022.